Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Estey · SciRah

Researcher profile · Semantic Scholar

E. Estey

Share profile

E. Estey — researcher profile on SciRah

h-index: 105
Works: 814
Citations: 46K

Most-cited papers

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.
D. Arber, A. Orazi, R. Hasserjian, M. Borowitz +64 more
2022Blood2,571 citations Open access
Semantic Scholar
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
E. Estey, R. Hasserjian, H. Döhner
2021Blood149 citations Open access
Semantic Scholar
Acute myeloid leukemia: 2021 update on risk‐stratification and management
E. Estey
2020American journal of hematology/oncology109 citations Open access
Semantic Scholar
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.
L. Angenendt, C. Röllig, P. Montesinos, D. Martínez-Cuadrón +41 more
2019Journal of Clinical Oncology103 citations Open access
Semantic Scholar
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
M. Biernacki, Kimberly A. Foster, Kyle B. Woodward, M. Coon +11 more
2020Journal of Clinical Investigation69 citations Open access
Semantic Scholar
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?
E. Estey, J. Karp, A. Emadi, M. Othus +1 more
2020Leukemia58 citations
Semantic Scholar
Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia
J. Cortes, M. D. de Lima, H. Dombret, E. Estey +5 more
2020Journal of Hematology & Oncology45 citations Open access
Semantic Scholar
More Versus Less Therapy for Older Adults With Acute Myeloid Leukemia: New Perspectives on an Old Debate.
H. Klepin, E. Estey, T. Kadia
2019American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting44 citations
Semantic Scholar
Multi-Site 11-Year Experience of Less-Intensive versus Intensive Therapies in Acute Myeloid Leukemia.
M. Sorror, B. Storer, A. Fathi, A. Brunner +27 more
2021Blood36 citations Open access
Semantic Scholar
Acute Myeloid Leukemia Measurable Residual Disease Detection by Flow Cytometry in Peripheral Blood Versus Bone Marrow.
Colin D. Godwin, Yi Zhou, M. Othus, Mallette M. Asmuth +5 more
2020Blood33 citations Open access
Semantic Scholar
Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function
Andreea Reilly, J. P. Creamer, Sintra Stewart, M. C. Stolla +13 more
2022Cell Stem Cell32 citations Open access
Semantic Scholar
Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.
Frances Linzee Mabrey, K. Gardner, Kathleen K. Shannon Dorcy, Andrea M. Perdue +13 more
2020Blood Advances31 citations Open access
Semantic Scholar
Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive models.
R. Walter, E. Estey
2020Blood reviews29 citations Open access
Semantic Scholar
Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia.
R. Cassaday, Kelsey-Leigh A Garcia, Jonathan R. Fromm, Mary-Elizabeth M. Percival +4 more
2020Blood Advances27 citations Open access
Semantic Scholar
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study *
S. Kayser, R. Hills, Ralitsa Langova, M. Kramer +27 more
2021British Journal of Haematology26 citations Open access
Semantic Scholar
Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia
Xue-Yan Chen, M. Othus, B. Wood, R. Walter +5 more
2020Leukemia and Lymphoma23 citations
Semantic Scholar
Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia.
Kylee L. Martens, P. Khalighi, Shan Li, Andrew A. White +6 more
2019Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis22 citations
Semantic Scholar
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study
S. Kayser, R. Hills, Marlise R. Luskin, A. Brunner +29 more
2019Haematologica21 citations Open access
Semantic Scholar
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm AML patients.
M. Sorror, T. Gooley, B. Storer, A. Gerds +21 more
2022Blood20 citations Open access
Semantic Scholar
Outpatient induction and consolidation care strategies in acute myeloid leukemia
A. Halpern, R. Walter, E. Estey
2019Current opinion in hematology19 citations
Semantic Scholar
Impact of Depth of Clinical Response on Outcomes of Acute Myeloid Leukemia Patients in First Complete Remission Who Undergo Allogeneic Hematopoietic Cell Transplantation
Mary-Elizabeth M. Percival, Hai-Lin Wang, Mei-Jie Zhang, W. Saber +63 more
2021Bone Marrow Transplantation18 citations Open access
Semantic Scholar
Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia
Alexander P. Hoffmann, Ashley L Besch, M. Othus, L. Morsink +5 more
2019Bone Marrow Transplantation18 citations Open access
Semantic Scholar
Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm
A. Halpern, N. P. Howard, M. Othus, P. Hendrie +15 more
2019Leukemia18 citations
Semantic Scholar
Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification.
M. Sorror, B. Storer, J. Nyland, E. Estey
2019JAMA Oncology18 citations Open access
Semantic Scholar
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants
L. Cicconi, A. Testi, P. Montesinos, E. Rego +19 more
2021Blood Cancer Journal17 citations Open access
Semantic Scholar
The wider perspective: twenty years of clinical trials in myelodysplastic syndromes
C. Duetz, D. Cucchi, T. Polak, Jeroen Janssen +3 more
2021British Journal of Haematology17 citations Open access
Semantic Scholar
Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.
Colin D. Godwin, Yi Zhou, M. Othus, Mallette M. Asmuth +5 more
2021Blood15 citations Open access
Semantic Scholar
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification
Michael J. Hochman, M. Othus, R. Hasserjian, A. Ambinder +7 more
2023Leukemia14 citations Open access
Semantic Scholar
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms
Gabrielle Paras, M. Othus, Kelda G Schonhoff, C. Shaw +7 more
2022Leukemia13 citations Open access
Semantic Scholar
Improved outcomes with “7+3” induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data
M. Othus, G. Garcia-Manero, J. Godwin, J. Weick +3 more
2022Haematologica13 citations Open access
Semantic Scholar
New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.
Noam E. Kopmar, E. Estey
2019Clinical advances in hematology & oncology : H&O13 citations
Semantic Scholar
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia
Mary-Elizabeth M. Percival, E. Estey
2019Cancer13 citations Open access
Semantic Scholar
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia
Kelsey-Leigh A Garcia, S. Cherian, P. Stevenson, C. Martino +10 more
2021Cancer11 citations
Semantic Scholar
Follow-up issues in survivors of hematologic malignancies - Current stance and future perspectives.
I. Muhsen, M. Bar, B. Savani, E. Estey +1 more
2020Blood reviews10 citations
Semantic Scholar
Time independent factors that predict relapse in adults with acute myeloid leukemia
John J Lim, M. Othus, C. Shaw, Kathryn Russell +6 more
2024Blood Cancer Journal9 citations Open access
Semantic Scholar
New treatments for acute myeloid leukemia: how much has changed?
E. Estey
2020Leukemia9 citations
Semantic Scholar
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
A. Halpern, E. Rodríguez-Arbolí, M. Othus, Kelsey-Leigh A Garcia +13 more
2023Blood Advances8 citations Open access
Semantic Scholar
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms
A. Halpern, M. Othus, N. P. Howard, P. Hendrie +10 more
2020Leukemia and Lymphoma7 citations
Semantic Scholar
Accurate Detection of Subclonal Variants in Paired Diagnosis-Relapse Acute Myeloid Leukemia Samples by Next Generation Duplex Sequencing
A. Kamath-Loeb, Jiang-Cheng Shen, Michael W. Schmitt, Brendan F. Kohrn +6 more
2022Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis6 citations Open access
Semantic Scholar
Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation
E. Krakow, R. Walter, Julia M. Nathe, Tess Perez +6 more
2022American journal of hematology/oncology6 citations Open access
Semantic Scholar
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy
A. Halpern, M. Othus, N. P. Howard, P. Hendrie +5 more
2021Leukemia and Lymphoma6 citations
Semantic Scholar
New study-designs to address the clinical complexity of acute myeloid leukemia
E. Estey, M. Othus, R. Gale
2019Leukemia6 citations Open access
Semantic Scholar
Phase II Study of Dose-Adjusted EPOCH as Initial Therapy for Adults with High-Risk Acute Lymphoblastic Leukemia
R. Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, O. Sala-Torra +16 more
2023Leukemia and Lymphoma5 citations Open access
Semantic Scholar
Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis.
Nathan Moore, M. Othus, A. Halpern, N. P. Howard +8 more
2021The Journal of the National Comprehensive Cancer Network5 citations Open access
Semantic Scholar
Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
R. Walter, F. Appelbaum, E. Estey
2020Leukemia5 citations
Semantic Scholar
Randomized Phase 1 Study of Sequential (“Primed”) vs. Concurrent Decitabine in Combination with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm
R. Palmieri, S. Buckley, M. Othus, A. Halpern +7 more
2020Leukemia and Lymphoma5 citations Open access
Semantic Scholar
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms
L. Shih, M. Othus, Kelda G Schonhoff, C. Shaw +6 more
2023Leukemia4 citations Open access
Semantic Scholar
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Colin D. Godwin, E. Rodríguez-Arbolí, M. Othus, A. Halpern +10 more
2022Cancers4 citations Open access
Semantic Scholar
Does intensity of induction chemotherapy affect the impact of measurable residual disease (MRD) on prognosis in acute myeloid leukemia (AML)?
Michael J. Hochman, M. Othus, C. Shaw, K. Gardner +3 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
Hyper‐CVAD versus dose‐adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia
Lucas C Zarling, P. Stevenson, Lorinda Soma, C. Martino +11 more
2023European Journal of Haematology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Walter×22
Invite
R. Walter — researcher profile on SciRah
Mary-Elizabeth M. Percival×20
Invite
Mary-Elizabeth M. Percival — researcher profile on SciRah
M. Othus×19
Invite
M. Othus — researcher profile on SciRah
A. Halpern×15
Invite
A. Halpern — researcher profile on SciRah

×13

Invite

P. Hendrie — researcher profile on SciRah

Invite

P. Becker — researcher profile on SciRah

Invite

C. Shaw — researcher profile on SciRah

Invite

R. Cassaday — researcher profile on SciRah

F. Appelbaum×7

Invite

F. Appelbaum — researcher profile on SciRah

Invite

V. Oehler — researcher profile on SciRah

Invite

K. Gardner — researcher profile on SciRah

Invite

S. Keel — researcher profile on SciRah